Mangia, A., Arleo, A., Piazzolla, V., Santoro, R., Petruzzellis, D., Miscio, M., et al. (2016). Sustained Virological Responses (SVR) of 97% in Genotype 2 (GT-2) Patients with F3/4 Stage of Fibrosis Treated with Sofosbuvir (SOF) and Weight-Based Ribavirin (RBV): A Real Life, Single Centre Experience. JOURNAL OF HEPATOLOGY, 64(2), S246-S247 [10.1016/s0168-8278(16)00257-9].
Sustained Virological Responses (SVR) of 97% in Genotype 2 (GT-2) Patients with F3/4 Stage of Fibrosis Treated with Sofosbuvir (SOF) and Weight-Based Ribavirin (RBV): A Real Life, Single Centre Experience
Arleo, A.;
2016
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
